How to treat hyperammonemia with an ammonia level of 200 μmol/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hyperammonemia with Ammonia Level of 200 μmol/L

For a patient with an ammonia level of 200 μmol/L, initiate both medical management with nitrogen scavengers and consider continuous kidney replacement therapy (CKRT), specifically high-dose continuous venovenous hemodialysis (CVVHD), as this level represents a threshold for increased mortality risk, especially in liver failure. 1, 2

Initial Medical Management

  • Stop protein intake immediately to prevent further ammonia production 1, 2
  • Administer intravenous glucose at 8-10 mg/kg/min to prevent catabolism 1
  • Provide intravenous lipids starting at 0.5 g/kg daily, up to 3 g/kg daily to ensure adequate caloric intake 1
  • Target caloric intake of ≥100 kcal/kg daily to prevent protein breakdown 1

Pharmacological Therapy (Nitrogen Scavengers)

  • Administer intravenous sodium benzoate and sodium phenylacetate as a bolus over 90-120 minutes followed by maintenance infusion over 24 hours 3:
    • For patients <20 kg: 250 mg/kg of each agent
    • For patients >20 kg: 5.5 g/m² of each agent
  • Add intravenous L-arginine hydrochloride (dose depends on specific urea cycle disorder) 1, 3:
    • For OTC and CPS deficiencies: 200 mg/kg (<20 kg) or 4 g/m² (>20 kg)
    • For ASS and ASL deficiencies: 600 mg/kg (<20 kg) or 12 g/m² (>20 kg)
  • For organic acidemias, add L-carnitine: 50 mg/kg loading dose over 90 minutes, then 100-300 mg/kg daily 1

Kidney Replacement Therapy

  • At ammonia level of 200 μmol/L, CKRT should be strongly considered, especially if there is evidence of encephalopathy 1, 4
  • CVVHD is the recommended first-line KRT modality for hyperammonemia 1
  • Warm the dialysate to maintain hemodynamic stability 1, 5
  • Target blood flow rate (Qb) of 30-50 ml/min with dialysate flow rate (Qd)/Qb >1.5 1
  • Continue CKRT until ammonia levels are <200 μmol/L on at least two consecutive hourly measurements 1

Monitoring During Treatment

  • Check plasma ammonia levels every 3-4 hours until normalized 1, 3
  • Monitor glutamine, quantitative plasma amino acids, blood glucose, electrolytes, venous or arterial blood gases, AST, and ALT 3
  • Assess neurological status, including Glasgow Coma Scale, for signs of encephalopathy 2, 3
  • Watch for signs of cerebral edema through clinical assessment or imaging 3

Decision Algorithm Based on Clinical Status

  1. If patient has moderate to severe encephalopathy (lethargy, decreased activity, hypotonia, etc.) or rapidly deteriorating neurological status: Initiate both nitrogen scavengers AND CKRT immediately 1
  2. If patient is neurologically stable but ammonia level is 200 μmol/L: Start nitrogen scavengers and reassess ammonia level and clinical status in 4 hours 3
  3. If ammonia level fails to decrease by 40% within 4-8 hours of nitrogen scavenger therapy: Add CKRT 3

Common Pitfalls and Caveats

  • Delayed recognition and treatment can lead to irreversible neurological damage; treat promptly 2, 6
  • Ammonia samples must be collected from free-flowing venous or arterial blood, transported on ice, and processed within 15 minutes to avoid false elevations 1, 2
  • Protein restriction should not be prolonged beyond 48 hours to avoid catabolism; reintroduce protein when ammonia levels return to 80-100 μmol/L 1
  • Nitrogen scavengers will be dialyzed during CKRT but can still be effective when used concurrently 1
  • Monitor for electrolyte disturbances during CKRT, particularly when using high-dose regimens 1, 5

Remember that ammonia levels ≥200 μmol/L represent a threshold above which mortality increases significantly, making aggressive treatment essential 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hyperammonemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Calculating Prefilter D5W Rate for Hyponatremic Patient on CRRT

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperammonemia in urea cycle disorders: A toxic metabolite for the brain.

Pediatrics international : official journal of the Japan Pediatric Society, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.